Thong Q. Le

SENIOR MANAGING DIRECTOR
CHAIRMAN

Thong Q. Le joined Accelerator Life Science Partners (ALSP) in 2013 and serves as Senior Managing Director and Chairman.   In this capacity, he led the firm’s expansion beyond the Pacific Northwest into NYC and Singapore, and established ALSP as a top venture catalyst in the life sciences sector.  His efforts have generated significant strategic and financial returns to ALSP’s stakeholders.

As a key component of his ALSP activities, Mr. Le oversees the firm’s venture-building efforts across two dedicated life science investment funds and served as a director and founding President & CEO of more than a dozen ALSP portfolio companies, including Petra Pharma (substantial acquisition by a global pharmaceutical company in May 2020), Rodeo Therapeutics (acquired by Amgen Inc. for up to $721 million in March 2021), and Lodo Therapeutics (acquired by Zymergen in May 2021, now Ginko Bioworks).  He currently serves as a director of ALSP portfolio companies Automera, Kayothera, and Proniras, and he also serves as an independent director of Oerth Bio and Ravenna Pharmaceuticals.

Prior to ALSP, Mr. Le served as a Managing Director at WRF Capital, the venture capital investment arm of Washington Research Foundation, where he focused on life science investments and supported company creation activities.  Prior to WRF Capital, Mr. Le was the founder, president and CEO of MiniMeals, Inc. and a consultant for Capital Management Consulting, Inc.  Earlier, he was at Raymond James & Associates, Singer & Xenos Investment Management Company and Capital Management Group LLC, a private investment firm specializing in biomedical ventures.

Mr. Le completed post-graduate studies at the Templeton College of Oxford University and received his A.B. cum laude in Government from Harvard University.  He serves on the advisory board for the Alexandria Seed Capital Platform and on the Board of Trustees for University Prep in Seattle, WA.